
    
      This is a randomized, double-blind, placebo-controlled study which will investigate the PK,
      safety, and tolerability of four ascending single and multiple oral doses of XG005 in healthy
      subjects. The trial consists of two parts: a single ascending dose (SAD) PK evaluation (Part
      1) and a multiple ascending dose (MAD) PK evaluation (Part 2). Approximately 32 Subjects will
      be enrolled sequentially into a total of 4 ascending dose levels in each part.
    
  